Patent · US Expired

Subcutaneous implants based on normegestrol derivatives

US5565443A · kind A · utility

8Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 1994
Grant dateOct 15, 1996
Priority date
Expiry dateMay 17, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P15/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Subcutaneous implant for preventing conception for at least one year in women comprising an amount effect to prevent conception without suppressing intermontly bleeding of a steroid compound of formula I or formula II and a physiologically-tolerable pharmaceutical carrier.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.